Ignite Creation Date:
2025-12-25 @ 4:22 AM
Ignite Modification Date:
2026-05-18 @ 1:23 PM
Study NCT ID:
NCT05941520
Status:
RECRUITING
Last Update Posted:
2025-10-07
First Post:
2023-07-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2023-05217
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None